Effect of periosteal reaction in medication-related osteonecrosis of the jaw on treatment outcome after surgery

J Bone Miner Metab. 2021 Mar;39(2):302-310. doi: 10.1007/s00774-020-01154-6. Epub 2020 Oct 12.

Abstract

Introduction: Surgical treatment in patients with medication-related osteonecrosis of the jaw (MRONJ) is superior to conservative treatment. However, treatment outcome in patients with periosteal reaction (PR) was significantly poorer than that of those without PR. The purpose of this retrospective study was to analyze the pathophysiology and clinical significance of PR in MRONJ.

Materials and methods: Out of 181 patients with MRONJ undergoing surgery, 38 patients with PR were enrolled in the study. CT examinations, histological examinations, and bacteriological examinations using real-time polymerase chain reaction were performed, and the relationship among the opted surgical method, CT findings, and treatment outcome was investigated.

Results: The pattern of PR was classified into three types: type 1, new bone is formed parallel to the mandible, and no gap was evident between the mandible and new bone; type 2, new bone is formed parallel to the mandible, and a gap was evident between them; type 3, an irregular shape. Histological examinations revealed inflammatory tissue in the area visualized as a gap on CT. Bacteriological examination showed the presence of bacteria in the type 2 or type 3 PR. Complete cure was observed in 21 of 38 (55.3%) patients, which was lower than the cure rate of 73.4% in 143 patients without PR. The cure rate was significantly lower in cases with type 3 PR or with persistent osteolysis.

Conclusions: It seems that complete resection of both osteolytic area and type 3 PR is necessary to obtain complete healing in patients undergoing marginal mandibulectomy.

Keywords: Antiresorptives; Clinical trials; Dental biology; Osteoporosis; Radiology.

Publication types

  • Observational Study

MeSH terms

  • Aged
  • Bisphosphonate-Associated Osteonecrosis of the Jaw / drug therapy
  • Bisphosphonate-Associated Osteonecrosis of the Jaw / surgery*
  • Bone Density Conservation Agents / adverse effects
  • Female
  • Humans
  • Male
  • Middle Aged
  • Periosteum / microbiology
  • Periosteum / pathology*
  • Preoperative Care
  • Retrospective Studies
  • Tomography, X-Ray Computed
  • Treatment Outcome

Substances

  • Bone Density Conservation Agents